No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Acetylation
-
Antineoplastic Agents / therapeutic use
-
Cell Differentiation / drug effects
-
Chromatin / metabolism*
-
Chromatin / ultrastructure
-
Chromosomal Proteins, Non-Histone / physiology
-
Core Binding Factor Alpha 2 Subunit
-
DNA-Binding Proteins / genetics
-
DNA-Binding Proteins / physiology
-
Enzyme Inhibitors / therapeutic use
-
Gene Expression Regulation, Leukemic*
-
Histone Deacetylase Inhibitors
-
Histone-Lysine N-Methyltransferase
-
Histones / chemistry
-
Histones / physiology
-
Humans
-
Leukemia / genetics*
-
Leukemia / metabolism
-
Leukemia, Promyelocytic, Acute / drug therapy
-
Leukemia, Promyelocytic, Acute / genetics
-
Leukemia, Promyelocytic, Acute / metabolism
-
Models, Genetic
-
Myeloid-Lymphoid Leukemia Protein
-
Neoplasm Proteins / physiology
-
Nucleic Acid Conformation
-
Nucleosomes / ultrastructure
-
Oncogene Proteins, Fusion / physiology
-
Protein Processing, Post-Translational
-
Proto-Oncogenes*
-
RUNX1 Translocation Partner 1 Protein
-
Recombinant Fusion Proteins / physiology
-
Static Electricity
-
Transcription Factors / physiology
-
Translocation, Genetic
-
Tretinoin / pharmacology
-
Tretinoin / therapeutic use
Substances
-
AML1-ETO fusion protein, human
-
Antineoplastic Agents
-
Chromatin
-
Chromosomal Proteins, Non-Histone
-
Core Binding Factor Alpha 2 Subunit
-
DNA-Binding Proteins
-
Enzyme Inhibitors
-
Histone Deacetylase Inhibitors
-
Histones
-
KMT2A protein, human
-
Neoplasm Proteins
-
Nucleosomes
-
Oncogene Proteins, Fusion
-
PLZF-RARalpha fusion protein, human
-
RUNX1 Translocation Partner 1 Protein
-
Recombinant Fusion Proteins
-
Transcription Factors
-
promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein
-
Myeloid-Lymphoid Leukemia Protein
-
Tretinoin
-
Histone-Lysine N-Methyltransferase